JP-1366 not checked

Onconic Therapeutics Inc. · Zastaprazan 20mg

FollowEvery change as it happens, and a Monday email
Stage
in other
Next date
Phase 3 trial completes
Trials
5 active
13 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“JP-1366 10 mg placebo, tablet, orally once a day for up to 24 weeks”In the company’s words, NCT06439563 on ClinicalTrials.gov
Tested for
Non-erosive Gastroesophageal Reflux Disease, Peptic Ulcer, H. Pylori Eradication Therapy, Maintenance of Healed Erosive Gastroesophageal Reflux Disease (ERD), Drug Drug Interaction (DDI)
Main trialPhase 3
“This study aims to evaluate the efficacy and safety of JP-1366 in Patients with NERD”In the company’s words, NCT07160790 on ClinicalTrials.gov
Other names
Zastaprazan 20mg

Other drugs for Peptic Ulcer

All 6 drugs for Peptic Ulcer

Coming up3

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials13

TrialPhaseCompletesWhat it tests
Phase 3Not yet recruiting 30 Jun 2026 Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease
Phase 3Recruiting Aug 2027 Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers
Phase 3Not yet recruiting 6 Sep 2028 Efficacy and Safety of JP-1366-based Triple Therapy in Helicobacter Pylori-positive Subjects
Phase 3Not yet recruiting 30 Oct 2028 Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive Esophagitis
Phase 1Recruiting 30 Mar 2026 to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban
Phase 3Completed 5 Jan 2023 JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis
Phase 3Completed 10 Jul 2024 Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer
Phase 2Completed 20 Oct 2020 Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease
Phase 1Completed 16 Jan 2021 Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers
Phase 1Completed 15 Mar 2021 Compare Pharmacokinetics and Safety of JP-1366 Between Korean and Caucasian
Phase 1Completed 9 Oct 2022 Clinical Trial to Evaluate the Safety and Pharmacokinetics of JP-1366 in Healthy Adult Volunteers
Phase 1Completed 4 May 2023 Clinical Trial to Evaluate Food-Effects on Pharmacokinetics and Pharmacodynamics of Oral Single Dose of JP-1366 Tablet in Healthy Volunteers
Phase 1Completed 20 Feb 2025 Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy Volunteers
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow JP-1366

Following is part of Solo: you see every change to JP-1366 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in